Kimberly-Clark supplements proxy disclosures in response to stockholder lawsuits over Kenvue merger

KIMBERLY CLARK CORP

Four lawsuits filed Dec 2025–Jan 2026 by Kenvue stockholders; one Delaware suit by K‑C stockholder.
Supplement adds details on strategic review committee formed June 30, 2025, and NDA terms with K‑C.
K‑C engaged Gibson Dunn for product liability due diligence; Kirkland disclosed Kenvue <1% of revenue.
J.P. Morgan expects ~$23.4M financing fees; aggregate fees from Kenvue $24M, from K‑C $11M.
Centerview updated DCF analysis implying K‑C equity value range of $119.14–$141.25 per share.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.